Xeris Biopharma Shares Rally on Lifted Guidance, 3Q Beat

By Elias SchisgallShares of Xeris Biopharma rallied after the company lifted its guidance and reported third-quarter results ahead of Wall Street's expectations.The stock was up 21% at $12.68 in Thursday trading. Shares have gained 62% this year.The biopharmaceutical company said it now expects rev…